Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Fasching

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological OncologyM P Lux, P A Fasching, C R Loehberg, et al.
Journal of Cancer Research and Clinical Oncology|April 5, 2008
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapyP A Fasching, B Kollmannsberger, P L Strissel, et al.
Der Radiologe|February 27, 2014
[Future of mammography-based imaging]R Schulz-Wendtland, T Wittenberg, T Michel, et al.
Oncology|June 3, 2008
Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancerD Laessig, H J Stemmler, U Vehling-Kaiser, et al.
Geburtshilfe Und Frauenheilkunde|February 9, 2016
Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-upR Schulz-Wendtland, P A Fasching, M R Bani, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|August 8, 2015
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]M Beckmann, C Sell, M Aydogdu, et al.
ESMO Open|October 26, 2024
Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancerK Seitz, C Goossens, H Huebner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trialG von Minckwitz, H Eidtmann, S Loibl, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 30, 2016
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]M W Beckmann, C Sell, M Aydogdu, et al.
Geburtshilfe Und Frauenheilkunde|October 10, 2014
Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-SeR Schulz-Wendtland, M Bani, M P Lux, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological OncologyM P Lux, P A Fasching, C R Loehberg, et al.
Journal of Cancer Research and Clinical Oncology|April 5, 2008
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapyP A Fasching, B Kollmannsberger, P L Strissel, et al.
Der Radiologe|February 27, 2014
[Future of mammography-based imaging]R Schulz-Wendtland, T Wittenberg, T Michel, et al.
Oncology|June 3, 2008
Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancerD Laessig, H J Stemmler, U Vehling-Kaiser, et al.
Geburtshilfe Und Frauenheilkunde|February 9, 2016
Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-upR Schulz-Wendtland, P A Fasching, M R Bani, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|August 8, 2015
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]M Beckmann, C Sell, M Aydogdu, et al.
ESMO Open|October 26, 2024
Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancerK Seitz, C Goossens, H Huebner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trialG von Minckwitz, H Eidtmann, S Loibl, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 30, 2016
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]M W Beckmann, C Sell, M Aydogdu, et al.
Geburtshilfe Und Frauenheilkunde|October 10, 2014
Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-SeR Schulz-Wendtland, M Bani, M P Lux, et al.
Pageof 11